Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Claudia Tandler

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Journal of Cancer Research and Clinical Oncology|May 13, 2022
BCR::ABL1 tyrosine kinase inhibitors hamper the therapeutic efficacy of blinatumomab in vitroJoseph Kauer, Melanie Märklin, Martin Pflügler, et al.
Cancers|September 26, 2020
Neutralization of B-Cell Activating Factor (BAFF) by Belimumab Reinforces Small Molecule Inhibitor Treatment in Chronic Lymphocytic LeukemiaClaudia Tandler, Moritz Schmidt, Jonas S Heitmann, et al.
Scientific Reports|December 5, 2019
CD105 (Endoglin) as negative prognostic factor in AMLJoseph Kauer, Karolin Schwartz, Claudia Tandler, et al.
Cancers|December 10, 2021
Receptor Activator of NF-κB (RANK) Confers Resistance to Chemotherapy in AML and Associates with Dismal Disease CourseKim L Clar, Lisa M Weber, Bastian J Schmied, et al.
Diagnostics (Basel, Switzerland)|November 27, 2021
Immunoprofiling of 4-1BB Expression Predicts Outcome in Chronic Lymphocytic Leukemia (CLL)Kübra Kaban, Sarah M Greiner, Samuel Holzmayer, et al.
Journal of Cellular and Molecular Medicine|September 21, 2020
C-Cbl regulates c-MPL receptor trafficking and its internalizationMelanie Märklin, Claudia Tandler, Hans-Georg Kopp, et al.
Frontiers in Oncology|April 5, 2021
Platelet-Expressed TNFRSF13B (TACI) Predicts Breast Cancer ProgressionClemens Hinterleitner, Yanjun Zhou, Claudia Tandler, et al.
Frontiers in Immunology|September 28, 2020
Genetic Loss of LCK Kinase Leads to Acceleration of Chronic Lymphocytic LeukemiaMelanie Märklin, Alexander R Fuchs, Claudia Tandler, et al.
Annals of Hematology|January 19, 2022
Identification of CD105 (endoglin) as novel risk marker in CLLSarah M Greiner, Melanie Märklin, Samuel Holzmayer, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|November 28, 2023
Long-term efficacy of the peptide-based COVID-19 T cell activator CoVac-1 in healthy adultsClaudia Tandler, Jonas S Heitmann, Tanja M Michel, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Journal of Cancer Research and Clinical Oncology|May 13, 2022
BCR::ABL1 tyrosine kinase inhibitors hamper the therapeutic efficacy of blinatumomab in vitroJoseph Kauer, Melanie Märklin, Martin Pflügler, et al.
Cancers|September 26, 2020
Neutralization of B-Cell Activating Factor (BAFF) by Belimumab Reinforces Small Molecule Inhibitor Treatment in Chronic Lymphocytic LeukemiaClaudia Tandler, Moritz Schmidt, Jonas S Heitmann, et al.
Scientific Reports|December 5, 2019
CD105 (Endoglin) as negative prognostic factor in AMLJoseph Kauer, Karolin Schwartz, Claudia Tandler, et al.
Cancers|December 10, 2021
Receptor Activator of NF-κB (RANK) Confers Resistance to Chemotherapy in AML and Associates with Dismal Disease CourseKim L Clar, Lisa M Weber, Bastian J Schmied, et al.
Diagnostics (Basel, Switzerland)|November 27, 2021
Immunoprofiling of 4-1BB Expression Predicts Outcome in Chronic Lymphocytic Leukemia (CLL)Kübra Kaban, Sarah M Greiner, Samuel Holzmayer, et al.
Journal of Cellular and Molecular Medicine|September 21, 2020
C-Cbl regulates c-MPL receptor trafficking and its internalizationMelanie Märklin, Claudia Tandler, Hans-Georg Kopp, et al.
Frontiers in Oncology|April 5, 2021
Platelet-Expressed TNFRSF13B (TACI) Predicts Breast Cancer ProgressionClemens Hinterleitner, Yanjun Zhou, Claudia Tandler, et al.
Frontiers in Immunology|September 28, 2020
Genetic Loss of LCK Kinase Leads to Acceleration of Chronic Lymphocytic LeukemiaMelanie Märklin, Alexander R Fuchs, Claudia Tandler, et al.
Annals of Hematology|January 19, 2022
Identification of CD105 (endoglin) as novel risk marker in CLLSarah M Greiner, Melanie Märklin, Samuel Holzmayer, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|November 28, 2023
Long-term efficacy of the peptide-based COVID-19 T cell activator CoVac-1 in healthy adultsClaudia Tandler, Jonas S Heitmann, Tanja M Michel, et al.
Pageof 2